China Healthcare, Regulatory and Reimbursement Landscape Report 2016 - China's Upcoming Pharma Market Boom: Over 650% Revenue Growth by 2020 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/psqrqx/countryfocus) has announced the addition of the "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China" report to their offering.

China's Upcoming Pharma Market Boom: Over 650% Revenue Growth by 2020

Considerable investment in China's pharmaceutical Research & Development (R&D) sector, along with numerous government-initiated reforms, will spark soaring growth in the country's pharmaceutical market in the near future, says a new report from research and consulting firm The authors.

According to the company's latest report on China's healthcare industry*, the country's pharmaceutical market value will climb from an estimated $48 billion in 2012 to a massive $315 billion in 2020, at a Compound Annual Growth Rate (CAGR) of 26.5%.

This increase will see China's pharmaceutical market become the second largest in the world, with surging revenue propelling industry value significantly closer to that of the US, which The authors forecasts to reach $475 billion in 2020.

An expanding and aging population will also play a key role in boosting China's pharmaceutical market revenue. With the country's elderly population expected to account for 19% of its total population of 1.41 billion in 2020, The authors expects to see a rising prevalence of chronic diseases, which will in turn spark an increasing demand for treatment.

This factor will also be a primary driver behind the rising value of China's medical device market - the second largest in Asia, behind Japan - which The authors forecasts will climb from $20 billion in 2012 to $54 billion in 2020.

This report identifies the key trends in China's healthcare market, providing insights into the demographic, regulatory and reimbursement landscape and the country's healthcare infrastructure, as well as the trends and segmentation of the Chinese pharmaceutical and medical device markets.

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Overview of Pharmaceutical and Medical Device Markets

4 Market Access

5 Country Analysis

6 Opportunities and Challenges

7 Appendix

For more information visit http://www.researchandmarkets.com/research/psqrqx/countryfocus

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Managed Care

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Managed Care